Cargando…

MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study

Sustained inflammation in the injured cortex is a promising therapeutic target for disease-modification after traumatic brain injury (TBI). However, its extent and dynamics of expansion are incompletely understood which challenges the timing and placement of therapeutics to lesioned area. Our aim wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasmin, Amna, Pitkänen, Asla, Jokivarsi, Kimmo, Poutiainen, Pekka, Gröhn, Olli, Immonen, Riikka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707062/
https://www.ncbi.nlm.nih.gov/pubmed/31474824
http://dx.doi.org/10.3389/fnins.2019.00863
_version_ 1783445802290511872
author Yasmin, Amna
Pitkänen, Asla
Jokivarsi, Kimmo
Poutiainen, Pekka
Gröhn, Olli
Immonen, Riikka
author_facet Yasmin, Amna
Pitkänen, Asla
Jokivarsi, Kimmo
Poutiainen, Pekka
Gröhn, Olli
Immonen, Riikka
author_sort Yasmin, Amna
collection PubMed
description Sustained inflammation in the injured cortex is a promising therapeutic target for disease-modification after traumatic brain injury (TBI). However, its extent and dynamics of expansion are incompletely understood which challenges the timing and placement of therapeutics to lesioned area. Our aim was to characterize the evolution of chronic inflammation during lesion expansion in lateral fluid-percussion injury (FPI) rat model with focus on the MRI-negative perilesional cortex. T2-weighted MR imaging (T2w MRI) and localized magnetic resonance spectroscopy (MRS) were performed at 1, 3, and 6 months post-injury. End-point histology, including Nissl for neuronal death, GFAP for astrogliosis, and Prussian Blue for iron were used to assess perilesional histopathology. An additional animal cohort was imaged with a positron emission tomography (PET) using translocator protein 18 kDa (TSPO) radiotracer [(18)F]-FEPPA. T2w MRI assessed lesion growth and detected chronic inflammation along the lesion border while rest of the ipsilateral cortex was MRI-negative (MRI-). Instead, myo-inositol that is an inflammatory MRS marker for gliosis, glutathione for oxidative stress, and choline for membrane turnover were elevated throughout the 6-months follow-up in the MRI- perilesional cortex (all p < 0.05). MRS markers revealed chronically sustained inflammation across the ipsilateral cortex but did not indicate the upcoming lesion expansion. Instead, the rostral expansion of the cortical lesion was systematically preceded by a hyperintense band in T2w images months earlier. Histologic analysis of the hyperintensity indicated scattered astrocytes, incomplete glial scar, and intracellularly packed and free iron. Yet, the band was negative in [(18)F]-FEPPA-PET. [(18)F]-FEPPA also showed no cortical TSPO expression within the MRS voxel in MRI- perilesional cortex or anywhere along glial scar when assessed at 2 months post-injury. However, [(18)F]-FEPPA showed a robust signal increase, indicating reactive microgliosis in the ipsilateral thalamus at 2 months post-TBI. We present evidence that MRS reveals chronic posttraumatic inflammation in MRI-negative perilesional cortex. The mismatch in MRS, MRI, and PET measures may allow non-invasive endophenotyping of beneficial and detrimental inflammatory processes to aid targeting and timing of anti-inflammatory therapeutics.
format Online
Article
Text
id pubmed-6707062
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67070622019-08-30 MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study Yasmin, Amna Pitkänen, Asla Jokivarsi, Kimmo Poutiainen, Pekka Gröhn, Olli Immonen, Riikka Front Neurosci Neuroscience Sustained inflammation in the injured cortex is a promising therapeutic target for disease-modification after traumatic brain injury (TBI). However, its extent and dynamics of expansion are incompletely understood which challenges the timing and placement of therapeutics to lesioned area. Our aim was to characterize the evolution of chronic inflammation during lesion expansion in lateral fluid-percussion injury (FPI) rat model with focus on the MRI-negative perilesional cortex. T2-weighted MR imaging (T2w MRI) and localized magnetic resonance spectroscopy (MRS) were performed at 1, 3, and 6 months post-injury. End-point histology, including Nissl for neuronal death, GFAP for astrogliosis, and Prussian Blue for iron were used to assess perilesional histopathology. An additional animal cohort was imaged with a positron emission tomography (PET) using translocator protein 18 kDa (TSPO) radiotracer [(18)F]-FEPPA. T2w MRI assessed lesion growth and detected chronic inflammation along the lesion border while rest of the ipsilateral cortex was MRI-negative (MRI-). Instead, myo-inositol that is an inflammatory MRS marker for gliosis, glutathione for oxidative stress, and choline for membrane turnover were elevated throughout the 6-months follow-up in the MRI- perilesional cortex (all p < 0.05). MRS markers revealed chronically sustained inflammation across the ipsilateral cortex but did not indicate the upcoming lesion expansion. Instead, the rostral expansion of the cortical lesion was systematically preceded by a hyperintense band in T2w images months earlier. Histologic analysis of the hyperintensity indicated scattered astrocytes, incomplete glial scar, and intracellularly packed and free iron. Yet, the band was negative in [(18)F]-FEPPA-PET. [(18)F]-FEPPA also showed no cortical TSPO expression within the MRS voxel in MRI- perilesional cortex or anywhere along glial scar when assessed at 2 months post-injury. However, [(18)F]-FEPPA showed a robust signal increase, indicating reactive microgliosis in the ipsilateral thalamus at 2 months post-TBI. We present evidence that MRS reveals chronic posttraumatic inflammation in MRI-negative perilesional cortex. The mismatch in MRS, MRI, and PET measures may allow non-invasive endophenotyping of beneficial and detrimental inflammatory processes to aid targeting and timing of anti-inflammatory therapeutics. Frontiers Media S.A. 2019-08-16 /pmc/articles/PMC6707062/ /pubmed/31474824 http://dx.doi.org/10.3389/fnins.2019.00863 Text en Copyright © 2019 Yasmin, Pitkänen, Jokivarsi, Poutiainen, Gröhn and Immonen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Yasmin, Amna
Pitkänen, Asla
Jokivarsi, Kimmo
Poutiainen, Pekka
Gröhn, Olli
Immonen, Riikka
MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_full MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_fullStr MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_full_unstemmed MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_short MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex – A 6-Months Multimodal Imaging Follow-Up Study
title_sort mrs reveals chronic inflammation in t2w mri-negative perilesional cortex – a 6-months multimodal imaging follow-up study
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707062/
https://www.ncbi.nlm.nih.gov/pubmed/31474824
http://dx.doi.org/10.3389/fnins.2019.00863
work_keys_str_mv AT yasminamna mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT pitkanenasla mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT jokivarsikimmo mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT poutiainenpekka mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT grohnolli mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy
AT immonenriikka mrsrevealschronicinflammationint2wmrinegativeperilesionalcortexa6monthsmultimodalimagingfollowupstudy